RecruitingNot Applicable

Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

United States24 participantsStarted 2026-05

Plain-language summary

The goal of this study is to: partner with Respiratory Health Association and determine barriers and unmet smoking cessation treatment needs from leaders in behavioral health organizations, treatment programs and adults who smoke (AWS) in Chicago. This will be accomplished by establishing a community advisory board (CAB) and pilot testing a community-informed smoking cessation treatment within a community behavioral health organization to determine its feasibility after addressing implementation issues.

Who can participate

Age range18 Years – 26 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Identify as someone who currently smokes combustible cigarettes (at least 1 cigarette per day) on each day for the past month * Report interest in quitting cigarettes (at least 6/10 scale in interest of quitting) * Age 18 or older, ability to understand the English language, willing and able to provide informed consent * Stable residence and contact information throughout the follow up period Exclusion Criteria: * Non-daily or intermittent cigarette use * No interest in quitting smoking * Unstable residence/not staying in Chicago for duration of study period * Current untreated severe substance use disorder (with the exception of tobacco use) or past-year serious untreated psychiatric illness (e.g. schizophrenia, bipolar disorder, obsessive compulsive disorder, unspecified psychosis, past-year suicide attempt)

What they're measuring

Number of participants who attend the enhanced intervention as assessed by enrollment and sign-in at each session

Timeframe: 3 months

Feasibility will be assessed by calculating the portion of people who enroll (attend at least on session) and complete 4+ sessions versus those who drop out before finishing 4 sessions as assessed by session sign-in

Timeframe: 3 months

A modified version of the Client Satisfaction Questionnaire (CSQ) will assess intervention acceptability.

Timeframe: End of treatment (e.g., 3 months or fourth session attended, whichever comes first)

Trial details

NCT IDNCT06837220

SponsorUniversity of Chicago

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09

Contact for this trial

Emma Brett, PhD

773-834-5341 ebrett@bsd.uchicago.edu

View on ClinicalTrials.gov More Nicotine Use Disorder trials

Plain-language summary

Who can participate

Age range18 Years – 26 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Number of participants who attend the enhanced intervention as assessed by enrollment and sign-in at each session

Timeframe: 3 months

A modified version of the Client Satisfaction Questionnaire (CSQ) will assess intervention acceptability.

Timeframe: End of treatment (e.g., 3 months or fourth session attended, whichever comes first)